Hinge Health, Inc. (HNGE) Guidance & Earnings Results
On 2026-08-04 Hinge Health, Inc. raised guidance: "Q3 2026 revenue $223-225M (+45% YoY at midpoint); FY26 revenue guidance midpoint raised to $858M (+46%…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
HNGEHinge Health, Inc.Follow HNGE — free
—
Price chart with a free account
- Market cap
- 9.0B
- P/E TTM
- 86.4
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 2 Nov, in 9 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 4 Aug 26 | Raised | Q3 2026 revenue $223-225M (+45% YoY at midpoint); FY26 revenue guidance midpoint raised to $858M (+46% YoY). · full year |
| 5 May 26 | Raised | FY2026 revenue guidance raised by ~$64M at midpoint to $801M · full year |
| 10 Feb 26 | Raised | Q1 2026 revenue $171M-$173M (39% YoY growth), FY2026 revenue $732M-$742M (25% YoY growth), non-GAAP operating margin 21%. |
| 4 Nov 25 | Raised | Revenue raised to $572-$574M; non-GAAP operating income raised to $106-$108M · full year |
| 5 Aug 25 | Raised | Q3 2025 revenue $141-143M (41% y/y growth); FY25 revenue $548-552M (41% y/y growth); FY25 non-GAAP income from operations $77-83M vs loss $26.1M in 2024 |
Hinge Health, Inc. — questions
- What guidance did Hinge Health, Inc. give?
- On 2026-08-04: "Q3 2026 revenue $223-225M (+45% YoY at midpoint); FY26 revenue guidance midpoint raised to $858M (+46% YoY)."
- When does Hinge Health, Inc. report earnings?
- Hinge Health, Inc.'s next earnings report is expected on 2026-11-02.
Every figure on this page comes from Hinge Health, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.